JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB195409

Anti-KMT6 / EZH2 antibody - ChIP Grade

0

(1 Review)

|

(12 Publications)

Rabbit Polyclonal KMT6 / EZH2 antibody. Suitable for ChIP, WB, ChIP-seq and reacts with Human samples. Cited in 12 publications. Immunogen corresponding to Recombinant Fragment Protein within Mouse Ezh2 aa 1-350.

View Alternative Names

KMT6, EZH2, Histone-lysine N-methyltransferase EZH2, ENX-1, Enhancer of zeste homolog 2, Lysine N-methyltransferase 6

3 Images
ChIP-sequencing - Anti-KMT6 / EZH2 antibody - ChIP Grade (AB195409)
  • ChIP-seq

Supplier Data

ChIP-sequencing - Anti-KMT6 / EZH2 antibody - ChIP Grade (AB195409)

ChIPseq results obtained with ab195409 directed against KMT6 / EZH2.

ChIP was performed on sheared chromatin from 4 million K562 cells using 2 μg of ab195409. The IP'd DNA was subsequently analysed on an Illumina HiSeq. Library preparation, cluster generation and sequencing were performed according to the manufacturer's instructions. The 51 bp tags were aligned to the human genome using the BWA algorithm. The figure shows the peak distribution along the short arm and a 6 Mb region containing several enriched regions of human chromosome 3 (figure A and B, respectively), and in two genomic regions containing the MYT1 gene on chromosome 20 and the HOX cluster on chromosome 7 (figure C and D).

ChIP - Anti-KMT6 / EZH2 antibody - ChIP Grade (AB195409)
  • ChIP

Supplier Data

ChIP - Anti-KMT6 / EZH2 antibody - ChIP Grade (AB195409)

ChIP results obtained with ab195409 directed against KMT6 / EZH2.

ChIP assays were performed using K562 cells, ab195409 and optimized PCR primer sets for qPCR. ChIP was performed using sheared chromatin from 4 million cells. A titration of the antibody consisting of 1, 2. 5 and 10 μg per ChIP experiment was analysed. IgG (2 μg/IP) was used as negative IP control. Quantitative PCR was performed with primers for MYT1 and HOXA9, used as positive control targets, and for the coding regions of the active CCT5 and EIF2S3 genes, used as negative controls. The figure shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).

Western blot - Anti-KMT6 / EZH2 antibody - ChIP Grade (AB195409)
  • WB

Supplier Data

Western blot - Anti-KMT6 / EZH2 antibody - ChIP Grade (AB195409)

The antiody was diluted in TBS-Tween containing 5% skimmed milk.

All lanes:

Western blot - Anti-KMT6 / EZH2 antibody - ChIP Grade (ab195409) at 1/1000 dilution

All lanes:

HeLa nuclear extract at 40 µg

Predicted band size: 85 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ChIP-seq, ChIP, WB

applications

Immunogen

Recombinant Fragment Protein within Mouse Ezh2 aa 1-350. The exact immunogen used to generate this antibody is proprietary information.

Q61188

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ChIP" : {"fullname" : "ChIP", "shortname":"ChIP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ChIPseq" : {"fullname" : "ChIP-sequencing", "shortname":"ChIP-seq"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ChIP-species-checked": "testedAndGuaranteed", "ChIP-species-dilution-info": "", "ChIP-species-notes": "<p>Use 2 μg/ChIP for chromatin prepared from 4x10<sup>6</sup> cells.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ChIPseq-species-checked": "testedAndGuaranteed", "ChIPseq-species-dilution-info": "", "ChIPseq-species-notes": "<p>Use 2 μg/ChIP for chromatin prepared from 4x10<sup>6</sup> cells</p>" }, "Mouse": { "ChIP-species-checked": "predicted", "ChIP-species-dilution-info": "", "ChIP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ChIPseq-species-checked": "predicted", "ChIPseq-species-dilution-info": "", "ChIPseq-species-notes": "" }, "Cynomolgus monkey": { "ChIP-species-checked": "predicted", "ChIP-species-dilution-info": "", "ChIP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ChIPseq-species-checked": "predicted", "ChIPseq-species-dilution-info": "", "ChIPseq-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Storage buffer
Preservative: 0.05% Sodium azide, 0.05% Proclin 300 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

KMT6 also known as EZH2 (Enhancer of Zeste Homolog 2) is a protein that functions as a histone methyltransferase. It catalyzes the methylation of histone H3 on lysine 27 (H3K27) a modification associated with gene silencing. EZH2 is a component of the Polycomb Repressive Complex 2 (PRC2) which plays an important role in chromatin remodeling and transcriptional repression. The EZH2 protein has a molecular weight of approximately 87 kDa and its gene is located on chromosome 7. In terms of expression EZH2 is found in various tissues but is notably abundant in growing and dividing cells.
Biological function summary

EZH2 plays a central role in regulating gene expression during development and differentiation. It is a core component of the PRC2 complex which includes other proteins such as EED and SUZ12. Through its catalytic activity EZH2 contributes to the maintenance of the transcriptionally repressed state of genes influencing processes such as cell identity and proliferation. In many cell types EZH2-mediated gene silencing is necessary for normal development and dysregulation can lead to aberrant cellular processes.

Pathways

EZH2 participates in key regulatory networks notably the Wnt signaling pathway and the p53 pathway. Within the Wnt pathway EZH2's activity contributes to controlling gene expression that influences cellular differentiation and proliferation. Meanwhile interaction with the p53 pathway can impact the cellular response to stress and DNA damage highlighting EZH2’s regulatory dimension. Other proteins like β-catenin in the Wnt pathway interact with EZH2 reflecting its integration in these complex signaling networks.

EZH2 has been linked to cancer and other proliferative diseases. Overexpression or mutation of EZH2 is frequently observed in cancers such as prostate and breast cancer where it contributes to unchecked cell growth and tumor progression. In these contexts proteins like p53 can interact abnormally with EZH2 leading to failure in tumor suppression mechanisms. Additionally deregulated EZH2 activity is implicated in certain developmental disorders highlighting its broader impact on cellular and organismal homeostasis.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Displays a preference for substrates with less methylation, loses activity when progressively more methyl groups are incorporated into H3K27, H3K27me0 > H3K27me1 > H3K27me2 (PubMed : 22323599, PubMed : 30923826). Compared to EZH1-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1, CDKN2A and retinoic acid target genes. EZH2 can also methylate non-histone proteins such as the transcription factor GATA4 and the nuclear receptor RORA. Regulates the circadian clock via histone methylation at the promoter of the circadian genes. Essential for the CRY1/2-mediated repression of the transcriptional activation of PER1/2 by the CLOCK-BMAL1 heterodimer; involved in the di and trimethylation of 'Lys-27' of histone H3 on PER1/2 promoters which is necessary for the CRY1/2 proteins to inhibit transcription.
See full target information EZH2

Publications (12)

Recent publications for all applications. Explore the full list and refine your search

Cell death discovery 8:103 PubMed35256601

2022

LncRNA MEG3 up-regulates SIRT6 by ubiquitinating EZH2 and alleviates nonalcoholic fatty liver disease.

Applications

Unspecified application

Species

Unspecified reactive species

Dongmei Zou,Liang Liu,Yinzhen Zeng,Huanhuan Wang,Dongling Dai,Mingguo Xu

Journal of microbiology and biotechnology 31:1358-1365 PubMed34409953

2021

LINC01232 Promotes Gastric Cancer Proliferation through Interacting with EZH2 to Inhibit the Transcription of KLF2.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Liu,Zhen Li,Guohua Yu,Ting Wang,Guimei Qu,Yunhui Wang

Cells, tissues, organs 209:227-235 PubMed33461200

2021

Targeting EZH2 Ameliorates the LPS-Inhibited PDLSC Osteogenesis via Wnt/β-Catenin Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Mosha Cheng,Qing Zhou

Frontiers in cell and developmental biology 8:552822 PubMed33330444

2020

LncRNA MAGI2-AS3 Overexpression Sensitizes Esophageal Cancer Cells to Irradiation Through Down-Regulation of HOXB7 EZH2.

Applications

Unspecified application

Species

Unspecified reactive species

Wenfang Cheng,Xiuling Shi,Mingqiang Lin,Qiwei Yao,Jiayu Ma,Jiancheng Li

Cancer cell international 20:551 PubMed33292225

2020

EZH2 promotes the expression of LPA1 by mediating microRNA-139 promoter methylation to accelerate the development of ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Dongbo Wu,Fanglan Wu,Birong Li,Wei Huang,Donglian Wang

Molecular oncology 14:3211-3233 PubMed33040438

2020

Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-κB/YY1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Jia Liu,Yang Zhan,Jiefu Wang,Junfeng Wang,Jiansheng Guo,Dalu Kong

Nature communications 11:3675 PubMed32699215

2020

Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Cao,Hayan Lee,Wei Wu,Aubhishek Zaman,Sean McCorkle,Ming Yan,Justin Chen,Qinghe Xing,Nasa Sinnott-Armstrong,Hongen Xu,M Reza Sailani,Wenxue Tang,Yuanbo Cui,Jia Liu,Hongyan Guan,Pengju Lv,Xiaoyan Sun,Lei Sun,Pengli Han,Yanan Lou,Jing Chang,Jinwu Wang,Yuchi Gao,Jiancheng Guo,Gundolf Schenk,Alan Hunter Shain,Fred G Biddle,Eric Collisson,Michael Snyder,Trever G Bivona

Cancer cell international 20:116 PubMed32308561

2020

Long non-coding RNA GAS5 accelerates oxidative stress in melanoma cells by rescuing EZH2-mediated CDKN1C downregulation.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Xu,Zeqiang Yan,Fen Hu,Wei Wei,Chao Yang,Zhihua Sun

Cell reports 29:1800-1811.e6 PubMed31722198

2019

A Functional Link between Nuclear RNA Decay and Transcriptional Control Mediated by the Polycomb Repressive Complex 2.

Applications

Unspecified application

Species

Unspecified reactive species

William Garland,Itys Comet,Mengjun Wu,Aliaksandra Radzisheuskaya,Leonor Rib,Kristoffer Vitting-Seerup,Marta Lloret-Llinares,Albin Sandelin,Kristian Helin,Torben Heick Jensen

Theranostics 9:4717-4729 PubMed31367252

2019

CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter.

Applications

Unspecified application

Species

Unspecified reactive species

Zhengang Qiu,Weiliang Zhu,Hui Meng,Lihua Tong,Xi Li,Peng Luo,Lilan Yi,Xiaoli Zhang,Linlang Guo,Ting Wei,Jian Zhang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com